Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Huangqi tablets (Fufang Huangqi Pian) is a traditional Chinese medicine (TCM) formulation primarily composed of Astragalus membranaceus (Huangqi) along with other herbal ingredients. It is traditionally used in China to replenish qi, consolidate the exterior, and treat symptoms such as shortness of breath, palpitations, and spontaneous sweating. In clinical research, compound Huangqi tablets are being evaluated in combination with hypomethylating agents like decitabine for the treatment of intermediate- to high-risk myelodysplastic syndrome (MDS) to improve hematopoiesis, boost immune function, and reduce treatment-related adverse effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on compound Huangqi tablets.